| Literature DB >> 28973668 |
Carolyne K Burgess1, Paul A Henning2,3, Wendy V Norman3, Meredith G Manze4, Heidi E Jones1.
Abstract
Purpose: No recommendations exist for routine reproductive intention screening in primary care. The objective of this systematic review is to assess the effect of reproductive intention screening in primary care on reproductive health outcomes (PROSPERO CRD42015019726).Entities:
Mesh:
Year: 2018 PMID: 28973668 PMCID: PMC5892170 DOI: 10.1093/fampra/cmx086
Source DB: PubMed Journal: Fam Pract ISSN: 0263-2136 Impact factor: 2.267
Figure 1.Diagram of systematic literature review on the effect of reproductive intention screening in primary care settings on reproductive health outcomes, 2000–17.
Chronological summary of studies assessing the effects of inclusion of reproductive intention screening in primary care setting on reproductive health outcomes
| First author (Year) | Study design | Sample | Reproductive intention screening exposure or intervention | Outcome measure(s) | Results on effectiveness of intervention/association with exposure (** for statistically significant findings) |
|---|---|---|---|---|---|
| de Jong-Potjer (2006) | Cluster RCT | 2276 female patients aged 18–40 from network of 67 GPs in the Netherlands |
| All participants assessed for anxiety at baseline questionnaire and retrospectively in the first trimester two months after pregnancy ended | **Within the intervention group, preconception counselling provided by the GP was associated with an average decrease of 3.6 points (95% CI 2.4–4.8) on the anxiety scale comparing anxiety before and after counselling. |
| Elsinga (2008) | Matched prospective cohort | 633 female patients aged 18–40 from network of 67 GPs in the Netherlands |
| Knowledge of healthy behaviours during pregnancy based on 20 essential items | **Women receiving PCC had statistically significantly higher knowledge scores on the 20 essential items (81.5% versus 76.9%, |
| Lee (2011) | Cross-sectional study | 770 female patients aged 18–50 years from four primary care clinics in Pennsylvania in need of contraceptive counselling based on reproductive intentions and non-use of contraception |
| Self-reported use of any reversible contraceptive method, hormonal method or highly effective reversible method at last intercourse 7–30 days after primary care visit | **In adjusted models, women who received contraceptive counselling had 2.68 (95% CI 1.48–4.87) times the odds of using hormonal contraceptive at last intercourse. |
| Schwarz 1 (2012) | Cluster RCT | 2304 female patients aged 18–50 years from 53 primary care physicians in a large, academic general internal medicine practice in Pennsylvania |
| Documentation of contraceptive use in medical chart at any visit and during visits that included prescription of teratogenic medication | **Significantly greater improvement in documentation of contraceptive use in the intervention group compared with the control group, with +77.4 (95% CI 70.7–84.1) adjusted percentage points in the intervention group compared with +3.1 (95% CI 1.2–5.0) in the control group ( |
| Schwarz 2 (2013a) | RCT | 515 female patients aged 18–45 in need of contraception per reproductive intention question from the waiting rooms of four urban acute care settings in Pennsylvania |
| Self-report having received contraceptive prescription, contraceptive use at last intercourse, unintentional pregnancy and contraceptive knowledge three months after clinic visit | **Women in the intervention arm were more likely to report having received contraception at the visit than women in control arm (16% versus 1%, |
| Schwarz 3 (2013b) | Quasi-experimental study | 801 female patients aged 18–50 from one of four community- based/academic general medicine clinics in Pennsylvania |
| Self-report receipt of counselling regarding medication-induced birth defects and/or contraception at their visit 5–30 days after index primary care visit | No difference in proportion of women who received potential teratogen being counselled about risk of birth defects or contraception between those seen during use of CDS versus those seen when CDS was not being used (57.5% versus 53.9%, |
| Stern (2013) | RCT | 299 Swedish-speaking female university students visiting a Student Health Center for contraception, chlamydia testing or cervical cancer screening in Sweden |
| Self-reported knowledge of benefits of folic acid and knowledge of reproduction score (out of 20) two months after clinic visit | **Women in the intervention arm were more likely to report the benefits of folic acid intake on pregnancy at follow-up (22% versus 3%, |
| Mittal (2014) | Quasi-experimental study | 27 non-pregnant Spanish or English-speaking female patients aged 18–40 years with diabetes, hypertension or obesity at hospital in San Francisco, CA |
| Self-report understands pregnancy risks associated with diabetes, hypertension and obesity directly after the clinic visit, based on Likert scale of 1 strongly disagree to 5 strongly agree | **More women reported agreeing that they understand the risks of pregnancy associated with all three conditions: |
| Bommaraju (2015) | Retrospective cohort | 771 self-identified Black, white or Latina female patients aged 16 years and older who received reproductive health services from the Cincinnati Health Department’s primary care health centrs during study period with at least a seven- week window in which to have a follow-up appointment to receive the contraceptive method of their choice |
| Contraceptive use at the end of the study period (no method/non-medical method/barrier; hormonal pills/patches/ rings; DMPA; or LARC/IUD/Implant) | Provision of RLPC was not associated with contraceptive use, 18.3% of women receiving RLPC were in the no method/non-medical/barrier method group; the proportion of women not receiving RLPC in this group was not reported. |
RCT, randomized control trial; CG, control group; RLP, reproductive life plan; PCC, preconception counselling; GP, general practitioner; DMPA, depot medroxyprogesterone acetate; RLPC, reproductive life plan counselling; LARC, long acting reversible contraception; CDS, clinical decision support; STAI, Spielberger State Trait Anxiety Inventory.
Summary of bias assessment scores using the JADAD (17) scale of randomized controlled trials included in systematic review by first author and year of publication
| de Jong-Potjer (2006) | Schwarz 1 (2012) | Schwarz 2 (2013a) | Stern (2013) | Points possible | |
|---|---|---|---|---|---|
| Described as randomized | 1 | 1 | 1 | 1 | 1 |
| Method of randomization described and appropriate | 1 | 0 | 0 | 0 | 1 |
| Described as double blinded | na | na | na | na | na |
| Method of double blinding described and appropriate | na | na | na | na | na |
| Withdrawals and dropouts described | 1 | 1 | 1 | 1 | 1 |
| Points (%) | 3/3 (100) | 2/3 (67) | 2/3 (67) | 2/3 (67) | 3 |
Double blinding not applicable to provider counselling, with cluster randomization.
na, not applicable.
Summary of bias assessment scores using the Newcastle-Ottawa scale (18,19) for observational studies included in systematic review by first author and year of publication
| Elsinga (2008) | Lee (2011) | Mittal (2014) | Schwarz (2013b) | Bommaraju (2015) | Possible points | |
|---|---|---|---|---|---|---|
| Representativeness of sample | 1 | 1 | 1 | 1 | 1 | 1 |
| Sample size | na | 0 | 0 | 0 | na | 1 |
| Non-respondents | na | 0 | 0 | 0 | na | 1 |
| Selection of the unexposed (cohort) | 1 | na | na | na | 1 | 1 |
| Outcome not present at start | 0 | na | na | na | 0 | 1 |
| Ascertainment of the exposure | 1 | 1 | 1 | 1 | 0 | 1 or 2 |
| Comparability | 2 | 2 | 2 | 2 | 2 | 2 |
| Assessment of the outcome | 1 | 2 | 2 | 1 | 1 | 2 |
| Statistical test | na | 1 | 1 | 1 | na | 1 |
| Adequate follow-up time | 1 | na | na | na | 1 | 1 |
| Adequacy of follow-up of cohort | 1 | na | na | na | 1 | 1 |
| Total points (%) | 8/9 (89) | 7/10 (70) | 7/10 (70) | 6/10 (60) | 7/9 (78) | 9 or 10 |
Na, not applicable for this type of study design.